Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» SPNC's 30-Y Financials


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q4 2016

SPNC Guru Trades in Q4 2016

John Hussman 140,000 sh (New)
Ron Baron 1,540,500 sh (+0.79%)
Jim Simons Sold Out
Paul Tudor Jones Sold Out
Steven Cohen 24,900 sh (-80.83%)
» More
Q1 2017

SPNC Guru Trades in Q1 2017

Jim Simons 61,922 sh (New)
Steven Cohen 205,667 sh (+725.97%)
John Hussman Sold Out
Ron Baron 1,301,500 sh (-15.51%)
» More
Q2 2017

SPNC Guru Trades in Q2 2017

Mario Gabelli 348,650 sh (New)
Leucadia National 130,000 sh (New)
John Paulson 237,500 sh (New)
Ron Baron 1,356,500 sh (+4.23%)
Jim Simons Sold Out
Steven Cohen 23,400 sh (-88.62%)
» More
Q3 2017

SPNC Guru Trades in Q3 2017

Ron Baron Sold Out
Leucadia National Sold Out
John Paulson Sold Out
Mario Gabelli Sold Out
Steven Cohen Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with SPNC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices    NAICS: 334510    SIC: 3845
Compare:SZSE:300298, HKSE:00853, NYSE:ITGR, TSE:3360, NAS:CNMD, SHSE:603387, SZSE:002317, OCSE:OSSR, SHSE:603579, XSWX:YPSN, XTAE:MZOR, NAS:AXGN, TSE:7817, HKSE:01302, NAS:WMGI, XTER:DRW3, SZSE:300273, NAS:XENT, SZSE:300326, NAS:OFIX » details
Traded in other countries:SC7.Germany,
Headquarter Location:USA
The Spectranetics Corp manufactures and sells single-use medical devices which are used to cross, prepare, and treat arterial blockages in the legs and heart and to remove pacemaker and defibrillator cardiac leads.

Spectranetics manufactures and sells single-use medical devices used in minimally invasive cardiovascular procedures. The firm operates in the three categories: vascular intervention, lead management, and laser, service, and other. The vascular intervention business contributes the majority of revenue and sells laser and aspiration catheters, balloon catheters, and support catheters. The lead management business sells devices used to remove pacemaker and defibrillator cardiac leads. The laser, service, and other business includes a laser system for cardiovascular procedures. Spectranetics generates the vast majority of its revenue in the United States.



Buy Back


Valuation & Return


More Statistics

Revenue (TTM) (Mil) $284.59
EPS (TTM) $ -1.59
52-Week Range $19.80 - 38.55
Shares Outstanding (Mil)44.05

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 302 364 462
EBIT (Mil $) -46 -27 0
EBITDA (Mil $) -21 -2 25
EPS ($) -1.51 -0.85 -0.13
EPS without NRI ($) -1.51 -0.85 -0.13
EPS Growth Rate
(Future 3Y To 5Y Estimate)
Dividends per Share ($)

Piotroski F-Score Details

Piotroski F-Score: ----
Positive ROAN
Positive CFROAN
Higher ROA yoyN
Lower Leverage yoyN
Higher Current Ratio yoyN
Less Shares Outstanding yoyN
Higher Gross Margin yoyN
Higher Asset Turnover yoyN

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat